Major study on Duchenne muscular dystrophy gains support

Harvard stem-cell research receives support from Sarepta Therapeutics for work on Duchenne muscular dystrophy.

Caroline Perry | Jan. 9, 2020 | harvard
~6 mins   

Tags: science-technology amy-wagers caroline-perry duchenne-muscular-dystrophy office-of-technology-development sarepta-therapeutics stem-cells

Treatments for touch hypersensitivity explored in new research

Harvard professors David Ginty and Lauren Orefice describe how their innovations present a novel approach to treating tactile hypersensitivity in patients with autism-spectrum disorders.

Caroline Perry | Jan. 8, 2020 | harvard
~15 mins   

Tags: science-technology autism basic-research david-ginty lauren-orefice office-of-technology-development tactile-hypersensitivity

Harvard chemists’ breakthrough advances potent anti-cancer agent

Chemists at Harvard and Eisai, a Japanese pharmaceutical company, have synthesized halichondrin, a potent anti-cancer agent found naturally in sea sponges. Because of the molecule’s “fiendishly complex” design, the feat took three decades.

Caroline Perry | June 17, 2019 | harvard
~7 mins   

Tags: health-medicine anti-cancer eisai halichondrin office-of-technology-development sea-sponge takashi-owa yoshito-kishi

Harvard: Sound transmitted by laser is ultra-high-speed Wi-Fi breakthrough

In a breakthrough on the road toward ultra-high-speed Wi-Fi, Harvard researchers have demonstrated for the first time a laser that can emit microwaves wirelessly, modulate them, and receive external radio frequency signals.

Leah Burrows | April 25, 2019 | harvard
~5 mins   

Tags: science-technology alexey-belyanin benedikt-schwarz christine-a-wang daniel-mcnulty federico-capasso harvard-office-of-technology-development john-a-paulson-school-of-engineering-and-applied-sciences laser-frequency-combs marco-piccardo michael-k-connors michele-tamagnone noah-a-rubin paul-chevalier quantum-cascade-laser-frequency seas wi-fi yongrui-wang

Harvard’s immune-silent stem cell technique licensed to Sana Biotechnology

Developed through Harvard’s Blavatnik Biomedical Accelerator, an innovative immune-silent stem cell technology could lead to novel cell therapies to treat “any patient with any disease.”

Caroline Perry | March 26, 2019 | harvard
~6 mins   

Tags: science-technology biotech blavatnik-biomedical-accelerator chad-cowan department-of-stem-cell-and-regenerative-biology isaac-t-kohlberg office-of-technology-development otd richard-mulligan sana-biotechnology steve-harr vivian-berlin

Symposium brings spheres together to lend insights to action for elderly

A half-day conference at Harvard Business School examined the growing promise of research on aging and the potential of now-experimental interventions to one day ease the burdens of infirmity.

Alvin Powell | Feb. 6, 2019 | harvard
~10 mins   

Tags: health-medicine aging alvin-powell caremore-health george-church harvard-business-school harvard-medical-school harvard-th-chan-school-of-public-health national-institute-on-aging office-of-technology-development richard-hodes sachin-jain

Page 1 of 1